Chemoresistance of negative costimulatory molecule B7-H4 to 786-O cells

LI Jinmei; SONG Hui; LIAN Qihui; CHEN Minji; ZHANG Liang; XIE Wei

doi:10.11665/j.issn.1000-5048.20130613

Journal of China Pharmaceutical University > 2013 > 44(6): 553-558. > DOI: 10.11665/j.issn.1000-5048.20130613

LI Jinmei, SONG Hui, LIAN Qihui, CHEN Minji, ZHANG Liang, XIE Wei. Chemoresistance of negative costimulatory molecule B7-H4 to 786-O cells[J]. Journal of China Pharmaceutical University, 2013, 44(6): 553-558. DOI: 10.11665/j.issn.1000-5048.20130613

Citation:

PDF (2122 KB)

Chemoresistance of negative costimulatory molecule B7-H4 to 786-O cells

More Information

Graphical Abstract

Abstract

Abstract

Human B7-H4 wild type gene was amplified by RT-PCR, digested with restriction endonuclease EcoR I and BamH I, and inserted into eukaryotic expression vector pIRES2-EGFP to construct recombinant eukaryotic expression vector pIRES2-EGFP-B7-H4-WT. The nuclear localization sequence(NLS)mutation type of B7-H4 was obtained by site-directed mutagenesis. The mutation type was then ligated with the vector pIRES2-EGFP and the recombinant eukaryotic expression vector pIRES2-EGFP-B7-H4-NLS-MT was constructed. The recombinant plasmids were transfected into 786-O cell line using Lipofectamine 2000 and three transgenic cells were constructed: Mock/786-O, B7-H4 WT/786-O and B7-H4 NLS MT/786-O. The cells proliferation and the cytotoxicity of chemotherapy drugs were assayed by CCK8 kit. The apoptosis of cells treated by 5-fluorouracil was assayed by Annexin V-PI/7ADD staining which detected by flowcytometry. Results showed that B7-H4 WT could effectively promote cell proliferation. When cells treated by various concentrations of 5-fluorouracil, doxorubicin and cisplatin B7-H4 WT/786-O cells were most resistant to drugs when compared with Mock/786-O and B7-H4 NLS MT/786-O, which suggested that B7-H4 wild type could confer chemoresistance to 786-O cells while B7-H4 NLS MT/786-O could not. The resistance index of B7-H4 WT/786-O cells to 5-5-fluorouracil was 2. 06, to doxorubicin was 1. 81 and to cisplatin was 1. 72. Flowcytometric analysis showed that when cells were treated with 1. 25 μg/mL 5-fluorouracil, the apoptosis of B7-H4 MT/786-O cells was lowest(20. 2%)when compared with Mock/786-O(41. 1%)and B7-H4 NLS MT/786-O(35. 1%). It showed that B7-H4 WT could confer multidrug resistance to 786-O cells through regulating cell apoptosis. However B7-H4 NLS MT could not act as an anti-apoptotic molecule. These results demonstrate that the NLS play an important role in the proliferation and chemoresistance promotion effect of B7-H4.
- B7-H4,
- renal cell carcinoma,
- 5-fluorouracil(5-Fu),
- nuclear localization sequence(NLS),
- chemoresistance

FullText(HTML)

References (22)

References

[1]	Sica GL,Choi IH,Zhu G,et al.B7-H4,a molecule of the B7 family,negatively regulates T cell immunity[J].Immunity,2003,18(6):849-861.
[2]	Prasad DV,Richards S,Mai XM,et al.B7S1 a novel B7 family member that negatively regulates T cell activation[J].Immunity,2003,18(6):863-873.
[3]	Zang X,Loke P,Kim J,et al.B7x:a widely expressed B7 family member that inhibits T cell activation[J].Proc Natl Acad Sci U S A,2003,100(18):10 388-10 392.
[4]	Ceeraz S,Nowak EC,Noelle RJ.B7 family checkpoint regulators in immune regulation and disease[J].Trends Immunol,2013,doi: 10.1016/j.it.2013.07.003.
[5]	Chen L,Lu Y,Wang F,et al.Expression of co-stimulatory molecule B7-H4 in patients suffering from rheumatoid arthritis[J].Immunol Lett,2013,154(1/2):25-30.
[6]	Carreno BM,Collins M.BTLA:a new inhibitory receptor with a B7-like ligand[J].Trends Immunol.2003,24(10):524-527.
[7]	Wang S,Chen L.Co-signaling molecules of the B7-CD28 family in positive and negative regulation of T lymphocyte responses[J].Microbes Infect,2004,6(8):759-766.
[8]	Choi IH, Zhu G, Sica GL, et al. Genomic organization and expression analysis of B7-H4,an immune inhibitory molecule of the B7 family[J].J Immunol,2003,171(9):4 650-4 654.
[9]	Hirotsune S,Yoshida N,Chen A,et al.An expressed pesudogene regulates the messenger-RNA stability of its homologous coding gene[J].Nature,2003,423(6 935):91-96.
[10]	Zhu J,Chu BF,Yang YP,et al.B7-H4 expression is associated with cancer progression and predicts patient survival in human thyroid cancer[J].Asian Pac J Cancer Prev,2013,14(5):3 011-3 015.
[11]	Qian Y,Hong B,Shen L,et al.B7-H4 enhances oncogenicity and inhibits apoptosis in pancreatic cancer cells[J].Cell Tissue Res,2013,353(1):139-151.
[12]	Krambeck AE,Thompson RH,Dong H,et al.B7-H4 expression in renal cell carcinorna and tumor vasculature:associations with cancer progression and survival[J].Proc Natl Acad Sci U S A,2006,103(27):10 391-10 396.
[13]	Simon I,Zhou S,Corral L,et al.B7-H4 is a novel membrane-bound protein and a candidate serum and tissue biomarker for ovarian cancer[J].Cancer Res,2006,66(3):1 570-1 575.
[14]	Li ZY,Zhang XH,Chen Y,et al.Clinical significance of B7-H4 expression in matched non-small cell lung cancer brain metastases and primary tumors[J].Oncol Targets Ther,2013,6:869-875.
[15]	Arigami T,Uenosono Y,Ishigami S,et al.Clinical significance of the B7-H4 coregulatory molecule as a novel prognostic marker in gastric cancer[J].World J Surg,2011,35(9):2 051-2 057.
[16]	Jiang J,Zhu Y,Wu C,et al.Tumor expression of B7-H4 predicts poor survival of patients suffering from gastric cancer[J].Cancer Immunol Immunother,2010,59(11):1 707-1 714.
[17]	Quandt D,Fiedler E,Boettcher D,et al.B7-H4 expression in human melanoma:its association with patients′ survival and antitumor immune response[J].Clin Cancer Res,2011,17(10):3 100-3 111.
[18]	Topalian SL,Hodi FS,Brahmer JR,et al.Safety,activity,and immune correlates of anti-PD-1 antibody in cancer[J].N Engl J Med,2012,366(26):2 443-2 454.
[19]	Brahmer JR,Tykodi SS,Chow LQ,et al.Safety and activity of anti-PD-L1 antibody in patients with advanced cancer[J].N Engl J Med,2012,366(26):2 455-2 465.
[20]	Dangaj D,Lanitis E,Zhao A,et al.Novel recombinant human B7-H4 antibodies overcome tumoral immune escape to potentiate T-cell antitumor responses[J].Cancer Res,2013,73(15):4 820-4 829.
[21]	Zhang L,Wu H,Lu D,et al.The costimulatory molecule B7-H4 promote tumor progression and cell proliferation through translocating into nucleus[J].Oncogene,2013,doi: 10.1038/onc.2012.600.
[22]	Kryczek I,Wei S,Zou L,et al.Cutting edge:induction of B7-H4 on APCs through IL-10:novel suppressive mode for regulatory T cells[J].J Immunol,2006,177(1):40-44.

[1]	ZHOU Hongyou, GAO Xiangdong, YAO Wenbing, TIAN Hong. Screening of adjuvant for PD-L1 vaccine based on nitrated T cell epitope[J]. Journal of China Pharmaceutical University, 2024, 55(3): 397-403. DOI: 10.11665/j.issn.1000-5048.2023032801
[2]	WANG Zhijie, LIAO Xiaotong, GUO Xia, CHEN Jianjun. New strategies for targeting PD-1/PD-L1: degraders, bifunctional molecules and covalent inhibitors[J]. Journal of China Pharmaceutical University, 2024, 55(1): 5-14. DOI: 10.11665/j.issn.1000-5048.2023112702
[3]	XU Shuyi, LI Yaxian, HU Hai, ZHANG Li, BIAN Yanlin, ZHU Jianwei, WU Mingyuan. Purification and activity of anti-PD-L1&CXCR4 bispecific nanobody[J]. Journal of China Pharmaceutical University, 2021, 52(5): 622-629. DOI: 10.11665/j.issn.1000-5048.20210516
[4]	CHEN Hongmei, KANG Yanliang, LIU Li, YAO Wenbing, TIAN Hong. Effects of different immunogenic amino acids in PD-L1 vaccine on the differentiation of T cell subsets[J]. Journal of China Pharmaceutical University, 2020, 51(3): 349-356. DOI: 10.11665/j.issn.1000-5048.20200313
[5]	WAN Nanyan, JIANG Cuihua, GAO Meng, ZHANG Jian, YIN Zhiqi, PAN Ke. Paeoniflorin inhibits programmed cell death-1-ligand 1 expression in HepG2 cells by regulating JAK/STAT3 signal pathway[J]. Journal of China Pharmaceutical University, 2019, 50(2): 213-221. DOI: 10.11665/j.issn.1000-5048.20190213
[6]	TIAN Jiping, ZHANG Jian, ZHOU Jinpei, ZHANG Huibin. Advances in small molecule inhibitors of PD-1/PD-L1 immune checkpoint pathway[J]. Journal of China Pharmaceutical University, 2019, 50(1): 1-10. DOI: 10.11665/j.issn.1000-5048.20190101
[7]	PAN Jiajia, JIA Xiaoqing, HUANG Gang, ZHANG Yubin. PD-1/PD-Ls signaling pathway and the application of anti-PD-1/PD-Ls antibodies in cancer therapy[J]. Journal of China Pharmaceutical University, 2016, 47(1): 9-18. DOI: 10.11665/j.issn.1000-5048.20160102
[8]	LI Xinran, LIU Rui, LIU Fangkun, LIU Yu. Culture process for fully human anti-VEGF165 monoclonal antibody[J]. Journal of China Pharmaceutical University, 2015, 46(6): 734-739. DOI: 10.11665/j.issn.1000-5048.20150617
[9]	MIAO You-pan, LI Ai-xiu, LIU Tao, WU Ke-zhu. Molecular designing strategies of anti-drug-resistant HIV-1 protease inhibitors[J]. Journal of China Pharmaceutical University, 2009, 40(3): 279-283.
[10]	Kong Lingyi, Li Yi, Min Zhida. Study on Analysis of Pd Ia in Peucedanum Praerupto rum and Pd C I in Peucedanum Decursivum by RP HPLC[J]. Journal of China Pharmaceutical University, 1996, (4).

Cited By

Get Citation

PDF

XML

Article views (1177) PDF downloads (1858)

Turn off MathJax

Article Contents

Abstract

References

Chemoresistance of negative costimulatory molecule B7-H4 to 786-O cells

Abstract

References

Related Articles

Catalog

Chemoresistance of negative costimulatory molecule B7-H4 to 786-O cells

Abstract

References

Related Articles

Catalog

Export File

Citation

Format

Content